Torsten Dr. Wagner

Torsten Dr. Wagner has a diverse work experience in the pharmaceutical industry. Torsten started their career in 1992 at Schering AG as a Scientist in Galenical and Pharmaceutical Development. Torsten then went on to become the Head of Production for Highly Potent Drugs and later the Head of Oral Dosage Forms. In 2004, they joined Schering AG - Bayer Pharma AG as the Head of Pharmaceutical Development. In 2008, they became the SVP Global Technical Operations at Merz Pharma GmbH & Co. KGaA.

Torsten Dr. Wagner’s education history starts in 1984, when they studied at Freie Universität Berlin. Torsten earned a degree in Pharmaceutics and worked towards becoming a pharmacist, graduating in 1989. Continuing their academic journey, Wagner pursued a Ph.D. in Pharmaceutical Technology at the same university from 1989 to 1994.

In 2003, Wagner attended Northwestern University's Kellogg School of Management, participating in an Executive Development Program. This program aimed to enhance their management skills and broaden their understanding of business strategies.

In 2010, Wagner furthered their education by enrolling in an unspecified program related to Business Administration at ESMT Berlin. The specific details of their degree are not mentioned publicly.

Finally, in 2014, Wagner attended the Advanced Management Program at Northwestern University's Kellogg School of Management. This program provided advanced training in management, leadership, and strategic decision-making.

Throughout their educational journey, Wagner progressively gained knowledge and expertise in various fields such as pharmaceutical technology, management, business administration, and executive development.